Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Motor Activity 1Chemotherapy-Related Cognitive Impairment 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 1258Specimen Handling 864Carboplatin 824Magnetic Resonance Spectroscopy 806Cyclophosphamide 798Cisplatin 719Nivolumab 660Paclitaxel 635Gemcitabine 570Radiotherapy 570Biopsy 526Bevacizumab 467Dexamethasone 441fludarabine 403Docetaxel 375venetoclax 369Oxaliplatin 363Capecitabine 355Fluorouracil 354atezolizumab 337Rituximab 333durvalumab 332Doxorubicin 316Pemetrexed 306Radiosurgery 304Drug Therapy 300Ipilimumab 296Standard of Care 288Etoposide 283Radiation 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Cognitive Training × 1 year × Clear all
NCT07085494 2026-01-27

Neurofeedback and Cognitive Training for PBTS

The University of Hong Kong

Phase NA Enrolling by invitation
50 enrolled
CNS

Brain Neoplasms

NCT07017530 2025-06-12

CHEMO-CogEx

Universidad de Extremadura

Phase NA Not yet recruiting
220 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡